These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 20031471

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Regression of cutis calcinosis with diltiazem in adult dermatomyositis.
    Abdallah-Lotf M, Grasland A, Vinceneux P, Sigal-Grinberg M.
    Eur J Dermatol; 2005; 15(2):102-4. PubMed ID: 15757822
    [Abstract] [Full Text] [Related]

  • 25. Localized calcinosis in juvenile dermatomyositis: successful treatment with intralesional corticosteroids injection.
    Al-Mayouf SM, Alsonbul A, Alismail K.
    Int J Rheum Dis; 2010 Aug; 13(3):e26-8. PubMed ID: 20704606
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment.
    Mukamel M, Horev G, Mimouni M.
    J Pediatr; 2001 May; 138(5):763-6. PubMed ID: 11343059
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis.
    Ostrov BE, Goldsmith DP, Eichenfield AH, Athreya BH.
    J Rheumatol; 1991 Nov; 18(11):1730-4. PubMed ID: 1787495
    [Abstract] [Full Text] [Related]

  • 30. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
    Wang A, Morgan GA, Paller AS, Pachman LM.
    J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Successful treatment of dermatomyositis and associated calcinosis with adalimumab.
    Xie F, Williams P, Batchelor R, Downs A, Haigh R.
    Clin Exp Dermatol; 2020 Oct; 45(7):945-949. PubMed ID: 33448458
    [No Abstract] [Full Text] [Related]

  • 33. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.
    Shahani L.
    BMJ Case Rep; 2012 Aug 18; 2012():. PubMed ID: 22907859
    [Abstract] [Full Text] [Related]

  • 34. Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis.
    Taborn J, Bole GG, Thompson GR.
    Ann Intern Med; 1978 Nov 18; 89(5 Pt 1):648-9. PubMed ID: 717938
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Dermatomyositis in children. Use of colchicine in outbreaks of calcinosis].
    Stalder JF, David A, Cohen JY, Barriere H.
    Presse Med; 1984 Feb 18; 13(7):441. PubMed ID: 6230618
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy.
    Touimy M, Janani S, Rachidi W, Etaouil N, Mkinsi O.
    Joint Bone Spine; 2013 Jan 18; 80(1):108-9. PubMed ID: 22999904
    [No Abstract] [Full Text] [Related]

  • 40. Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy.
    Vinen CS, Patel S, Bruckner FE.
    Rheumatology (Oxford); 2000 Mar 18; 39(3):333-4. PubMed ID: 10788545
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.